Q4 2024 |
56 |
$988M |
+$141M |
-$257M |
-$116M |
TECK, BAC, APO, WYNN, FCX
|
13F-HR |
2/14/2025, 05:12 PM |
Q3 2024 |
48 |
$1.13B |
+$193M |
-$91.8M |
+$101M |
TECK, FCX, APO, WYNN, BAC
|
13F-HR |
11/5/2024, 07:51 PM |
Q2 2024 |
46 |
$965M |
+$201M |
-$235M |
-$34.2M |
TECK, APO, BAC, WYNN, WFC
|
13F-HR |
8/1/2024, 08:11 PM |
Q1 2024 |
48 |
$990M |
+$166M |
-$213M |
-$46.9M |
TECK, APO, FCX, BAC, WYNN
|
Restatement |
5/14/2024, 07:27 PM |
Q4 2023 |
40 |
$940M |
+$610M |
-$152M |
+$458M |
TECK, FCX, APO, BAC, WYNN
|
Restatement |
5/14/2024, 07:29 PM |
Q3 2023 |
48 |
$448M |
+$159M |
-$160M |
-$792K |
KVUE, TECK, CME, GEHC, AMZN
|
13F-HR |
11/13/2023, 06:52 PM |
Q2 2023 |
45 |
$458M |
+$117M |
-$199M |
-$82.1M |
CME, AMZN, GEHC, SLB, PINS
|
13F-HR |
8/14/2023, 08:34 PM |
Q1 2023 |
50 |
$513M |
+$139M |
-$112M |
+$26.7M |
AMZN, CME, DIS, GEHC, PINS
|
13F-HR |
5/15/2023, 05:29 PM |
Q4 2022 |
47 |
$428M |
+$73.3M |
-$94.6M |
-$21.4M |
AMZN, CME, PINS, MA, DIS
|
Restatement |
8/15/2023, 08:24 PM |
Q3 2022 |
40 |
$476M |
+$46.9M |
-$136M |
-$88.8M |
AMZN, CME, MA, PINS, SLB
|
Restatement |
8/15/2023, 08:20 PM |
Q2 2022 |
31 |
$588M |
+$185M |
-$42.3M |
+$142M |
AMZN, CME, MA, PINS, TWTR
|
Restatement |
9/9/2022, 12:38 PM |
Q1 2022 |
17 |
$772M |
+$86.2M |
-$60.3M |
+$25.8M |
AMZN, CME, MA, XM, PINS
|
13F-HR |
5/16/2022, 10:01 AM |
Q4 2021 |
14 |
$834M |
+$34.9M |
-$46.2M |
-$11.3M |
AMZN, MA, CME, PINS, XM
|
13F-HR |
2/14/2022, 03:21 PM |
Q3 2021 |
14 |
$910M |
+$11.8M |
-$231M |
-$219M |
AMZN, MA, PINS, CME, XM
|
13F-HR |
11/15/2021, 03:01 PM |
Q2 2021 |
18 |
$1.26B |
+$252M |
-$199M |
+$53.1M |
AMZN, PINS, MA, CME, OTIS
|
13F-HR |
8/16/2021, 10:51 AM |
Q1 2021 |
16 |
$1.13B |
+$178M |
-$45.4M |
+$132M |
AMZN, MA, PINS, CME, OTIS
|
13F-HR |
5/14/2021, 07:19 PM |
Q4 2020 |
13 |
$969M |
+$151M |
-$36.8M |
+$115M |
AMZN, MA, PINS, CME, OTIS
|
13F-HR |
2/16/2021, 09:41 AM |
Q3 2020 |
7 |
$757M |
+$129M |
-$42.8M |
+$85.8M |
AMZN, MA, CME, PINS, OTIS
|
13F-HR |
11/16/2020, 12:47 PM |
Q2 2020 |
9 |
$851M |
+$59.1M |
-$164M |
-$105M |
AMZN, MA, LINXXXX, CME, CL
|
13F-HR |
8/14/2020, 10:16 AM |
Q1 2020 |
8 |
$928M |
+$22.6M |
-$106M |
-$83.3M |
CME, AMZN, MA, LINXXXX, SPOT
|
13F-HR |
5/15/2020, 03:57 PM |
Q4 2019 |
10 |
$1.27B |
+$33M |
-$781K |
+$32.2M |
CME, AMZN, MA, CL, SPOT
|
13F-HR |
2/14/2020, 01:44 PM |
Q3 2019 |
10 |
$1.17B |
+$40.4M |
-$30.8M |
+$9.61M |
CME, AMZN, MA, CL, LINXXXX
|
13F-HR |
11/14/2019, 01:39 PM |
Q2 2019 |
10 |
$1.18B |
+$134M |
|
+$134M |
CME, AMZN, MA, CL, SPOT
|
13F-HR |
8/14/2019, 04:34 PM |
Q1 2019 |
11 |
$986M |
+$14.2M |
-$42.6M |
-$28.4M |
CME, AMZN, MA, CL, LINXXXX
|
13F-HR |
5/14/2019, 09:18 AM |
Q4 2018 |
10 |
$928M |
+$197M |
|
+$197M |
CME, AMZN, CL, MA, LINXXXX
|
13F-HR |
2/14/2019, 08:57 AM |
Q3 2018 |
11 |
$962M |
+$59.8M |
-$46M |
+$13.9M |
CME, AMZN, MA, CL, PX
|
13F-HR |
11/14/2018, 01:47 PM |
Q2 2018 |
11 |
$909M |
+$75.1M |
-$14.6M |
+$60.5M |
CME, AMZN, MA, CL, PX
|
13F-HR |
8/14/2018, 10:35 AM |
Q1 2018 |
11 |
$818M |
+$125M |
-$24.2M |
+$101M |
CME, AMZN, MA, CL, KO
|
13F-HR |
5/11/2018, 05:02 PM |
Q4 2017 |
10 |
$690M |
+$180M |
-$7.39M |
+$172M |
CME, AMZN, MA, Z, CL
|
13F-HR |
2/14/2018, 08:15 AM |
Q3 2017 |
11 |
$494M |
+$45.9M |
|
+$45.9M |
CME, MA, AMZN, Z, PX
|
13F-HR |
11/14/2017, 08:44 AM |
Q2 2017 |
10 |
$458M |
+$40.8M |
-$47.7M |
-$6.84M |
CME, AMZN, MA, Z, PX
|
13F-HR |
8/14/2017, 10:15 AM |
Q1 2017 |
12 |
$506M |
+$90.6M |
|
+$90.6M |
CME, MA, AMZN, MJN, NLSN
|
13F-HR |
5/15/2017, 09:01 AM |
Q4 2016 |
10 |
$397M |
+$69.9M |
-$24.3M |
+$45.6M |
CME, MA, AMZN, Z, NLSN
|
13F-HR |
2/14/2017, 01:38 PM |
Q3 2016 |
10 |
$384M |
+$35.8M |
-$7.19M |
+$28.6M |
CME, MA, AMZN, MJN, Z
|
13F-HR |
11/14/2016, 03:41 PM |
Q2 2016 |
11 |
$345M |
+$10.9M |
-$6.98M |
+$3.89M |
CME, MA, MJN, AMZN, Z
|
13F-HR |
8/15/2016, 12:17 PM |
Q1 2016 |
11 |
$353M |
+$85.3M |
-$6.31M |
+$78.9M |
CME, MA, MJN, AMZN, HOUS
|
13F-HR |
5/13/2016, 04:25 PM |
Q4 2015 |
12 |
$294M |
+$49.7M |
-$5.81M |
+$43.9M |
MA, CME, AMZN, HOUS, WDFC
|
Restatement |
2/17/2016, 08:01 AM |
Q3 2015 |
13 |
$248M |
+$51M |
-$3.53M |
+$47.5M |
MA, CME, AMZN, HOUS, MRKT
|
13F-HR |
11/13/2015, 02:09 PM |
Q2 2015 |
12 |
$229M |
+$34.4M |
-$16.6M |
+$17.8M |
MA, CME, HOUS, WDFC, AMZN
|
13F-HR |
8/14/2015, 09:26 AM |
Q1 2015 |
13 |
$222M |
+$53.3M |
-$14M |
+$39.2M |
MA, CME, HOUS, WDFC, AMZN
|
13F-HR |
5/15/2015, 09:23 AM |
Q4 2014 |
10 |
$190M |
+$30.9M |
-$10.3M |
+$20.6M |
CME, MA, HOUS, WDFC, ZXXXX
|
13F-HR |
2/13/2015, 01:59 PM |
Q3 2014 |
11 |
$200M |
+$69.4M |
-$54.9M |
+$14.5M |
CME, HOUS, MNSTXXXX, WDFC, ZXXXX
|
13F-HR |
11/13/2014, 05:06 PM |
Q2 2014 |
8 |
$199M |
+$220K |
-$81.3M |
-$81.1M |
CME, MNSTXXXX, MHFI, WDFC, FOX
|
Restatement |
9/5/2014, 05:15 PM |
Q1 2014 |
11 |
$342M |
+$49.1M |
-$4.38M |
+$44.7M |
HOUS, WWE, CME, MHFI, MNSTXXXX
|
13F-HR |
5/15/2014, 09:25 AM |
Q4 2013 |
11 |
$312M |
|
|
|
HOUS, MHFI, CME, MNSTXXXX, WWE
|
13F-HR |
2/13/2014, 08:37 AM |